特朗普发出威胁！两项关键商品，关税50%和200%！价格迅速暴涨→

Core Viewpoint - The article discusses the potential implementation of significant tariffs on pharmaceuticals and copper imports by the U.S. government, which could impact related industries and companies significantly [1][2]. Group 1: Tariffs on Pharmaceuticals - President Trump announced plans to impose tariffs of up to 200% on imported pharmaceuticals and related products, giving companies about one to one and a half years to adjust [1]. - The announcement indicates a shift in U.S. trade policy aimed at protecting domestic industries [2]. Group 2: Tariffs on Copper - Trump confirmed a 50% additional tariff on imported copper, with the implementation expected by the end of July or early August [2]. - The U.S. Commerce Secretary stated that the investigation into the national security implications of copper imports has been completed, and the government is moving forward with the tariff process [2]. Group 3: Market Reaction - Following the tariff announcements, U.S. copper prices surged, with COMEX copper futures rising by 13.25% to $5.6450 per pound, marking the largest single-day increase since 1968 [1]. - Freeport-McMoRan, a major copper producer, saw its stock price increase by nearly 5% in intraday trading, with a cumulative rise of 58% over the past three months [3]. Group 4: Import Sources - According to U.S. statistics, Chile, Canada, and Mexico are the top three sources of refined copper and copper products imported by the U.S. in 2024, likely to be the most affected by the new tariffs [4].